Compare MXL & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | GCTK |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.6M |
| IPO Year | 2010 | N/A |
| Metric | MXL | GCTK |
|---|---|---|
| Price | $19.51 | $1.65 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.80 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 942.2K |
| Earning Date | 01-29-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $467,641,000.00 | N/A |
| Revenue This Year | $21.57 | N/A |
| Revenue Next Year | $11.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.71 | N/A |
| 52 Week Low | $8.35 | $1.52 |
| 52 Week High | $20.82 | $40.78 |
| Indicator | MXL | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 25.13 |
| Support Level | $18.24 | $1.60 |
| Resistance Level | $19.78 | $1.89 |
| Average True Range (ATR) | 1.20 | 0.27 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 73.71 | 7.77 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.